Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis - Wikidata - awgldk - TriplyDB

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis

http://www.wikidata.org/entity/Q30538670

about

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease Hepatic lipid droplet biology: Getting to the root of fatty liver Short term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout mice Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory State Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice.Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis.Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation.Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats.Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine.Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation A novel transgenic mouse model of lysosomal storage disorder Cholesterol is a significant risk factor for non-alcoholic steatohepatitis.Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH.Role of inflammatory response in liver diseases: Therapeutic strategies.Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.Deficiency of cholesterol 7α-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice.Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol

P2860

Q26742102-DFBF9B92-2E86-4404-9BB4-6E98D6CE0D48 Q26798157-8AAFE84B-F8D9-4B09-B319-57284B89A618 Q28087033-5BA528F5-E116-4378-9F75-65E8656C66D3 Q33599367-154A4479-DDA6-4454-A3BA-1FC1C88426FC Q33678636-B70589BD-CE97-4865-8B1E-02547E6B342C Q34750494-BD22795B-BBF3-4393-BC0E-954369503A64 Q34750585-860A31E9-4C56-496E-885A-74DB1F61D126 Q35014238-FAA9F4F3-5752-437A-B915-95766CCE44EB Q35070019-FBDFB14F-89C3-48B6-87D1-F3CDA33E8163 Q35588868-EE4E3C5C-AA6B-4E64-84D7-44B10B7E594F Q35822068-0CB95E46-90CA-4059-9152-241A20D67393 Q36184055-21617A2A-B5DF-44B5-9BB1-F6EEB5C30160 Q36933396-E537111C-3550-4B68-A91D-CAFF6F3081B0 Q37355594-E03D31BD-C7B4-4B5D-A839-D4B6C5697338 Q38195943-0BBD8597-CAAA-4F22-A871-E20646E82D62 Q38365029-8523CEAF-793B-41B3-A210-5EB9F78D7E2D Q38872713-962CB5DB-D6E1-4B1B-81C2-FE544BF0BC92 Q40088550-C499DABC-05AE-4DE0-B1BC-473472D61C05 Q40587873-D73890D0-5602-423A-AE7E-C38F8AACC3B6 Q40691956-623D0A11-5E75-4D4F-9152-B6DE6D63ED50 Q40979699-430D6D04-385C-4144-8DF7-0360294803D9 Q41230267-AEC82F31-3332-45FD-92A9-B56A8CF5E221 Q41649308-220ADD40-3E85-4E3D-8174-353522590630 Q41927137-032BF6B8-413E-4565-955E-6B9D51BE6C42 Q42286045-F6AC111A-6510-4F0A-988C-2B302C114695 Q42784240-95293716-531C-424B-AD19-8E6632F13D48 Q46665876-3D88B627-15A9-4181-8AFA-CC91EA37F067 Q47608553-8917CC14-B34F-43D6-83D7-3A41FB98BF5E Q47917331-EF60183F-3BF5-4F86-B7B3-C2009A6FCD09 Q48513535-B02C61AB-3A62-4B20-BCF1-0D8334DF7C7A Q50878523-3B50332A-D81D-4567-89AB-69AA49C998FD Q51736940-B3DE9B81-83ED-4684-8A7E-5A69A2A79C2B Q55080645-50397275-CCB8-4535-9545-B4AE7173D7FA Q55251257-48BD7860-9B80-458D-9FF0-5022F29470A1 Q55257499-FD4F9C19-C715-4081-9C59-0B24437C61DE Q55425011-5165C38E-B096-4486-8D3A-2CA8FA51755E Q56507689-3A85BEEE-63F1-4CBF-8011-C77AA218748B Q58316278-D5488CF5-580D-4728-9DEC-FCDE0613DEFA Q58596151-41058EBE-750B-43D2-A6A8-F9C499DC6CEE Q58722819-4DA3C7D5-77A7-4733-952F-55FD7990D97A

P2860

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis

http://www.wikidata.org/entity/Q30538670

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@ast

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@en

type

label

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@ast

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@en

prefLabel

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@ast

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@en

P1433

Q30538670-93E2575D-8BCC-4599-ADA5-FA7C4590F053

P1476

Q30538670-C58A59E3-9321-4AF1-A7A5-B56A2368C89B

P2093

Q30538670-00519BE1-6E09-4DE0-BECA-91BFF58DC51B

Q30538670-3587E9AE-4F1E-44CF-ACD1-5B7BB46B3EA3

Q30538670-65B94DA4-B4FC-474E-9F02-ED21A36EFAA1

Q30538670-EF5B8A8D-07A4-4D0E-95BF-10BCEBF47E18

P2860

Q30538670-02B4CF57-D803-48D8-A825-55248AC92D5D

Q30538670-231FEA43-0D04-4054-BD33-1BD8DC18F674

Q30538670-2478CE82-AD58-4B4B-B8A1-18562F25B0BA

Q30538670-274F1CCF-8FE9-4229-9B23-F2DE13B307A5

Q30538670-2E5CB89C-D49A-4828-8EBC-092A73C15026

Q30538670-45BEE79D-26B5-40C0-96F9-BDD78A32366F

Q30538670-46994C6D-1367-4684-B768-3D0D7E2917BF

Q30538670-4FC875AD-71BB-40BC-AB63-98AB8A81D7C7

Q30538670-579366CD-B517-4A01-B74C-D7301CB828FB

Q30538670-58DB2B80-2216-4420-9B77-31E53FEF4375

P304

Q30538670-85390BA4-1E22-4A7A-9434-53DE2E3CC7F5

P31

Q30538670-8E9656DE-EA5E-4A4E-BC53-EDEB9A5C1CBD

P356

Q30538670-6911C3C8-FA70-4A3E-9E04-60744E1F3522

P433

Q30538670-AE0D5A5F-34B1-42DE-84F8-2258FD6DFD93

P478

Q30538670-BC1E79FF-4569-4AA4-B2E4-DA30D92CC723

P577

Q30538670-04466AB6-61FA-49C9-880D-70C8C76DBAAE

P698

Q30538670-853E3837-109B-4EBE-B94E-6890A4D7A4BC

P932

Q30538670-F950BA81-BAF7-466D-9B90-C0614C1929E5

P356

P1433

Journal of Lipid Research

P1476

Hepatic cholesterol crystals a ...... ish NASH from simple steatosis

@en

P2093

Christopher Savard

http://www.w3.org/2001/XMLSchema#string

David Thorning

http://www.w3.org/2001/XMLSchema#string

George N Ioannou

http://www.w3.org/2001/XMLSchema#string

W Geoffrey Haigh

http://www.w3.org/2001/XMLSchema#string

P2860

A simple method for the isolation and purification of total lipides from animal tissues

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.

Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

P304

1326-1334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M034876

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23417738

http://www.w3.org/2001/XMLSchema#string

P932

3622327

http://www.w3.org/2001/XMLSchema#string